Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
about
Thioredoxin reductaseHuman thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparinThioredoxin reductase is the major selenoprotein expressed in human umbilical-vein endothelial cells and is regulated by protein kinase CROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stromaDifferential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.Acetaminophen reactive intermediates target hepatic thioredoxin reductaseSusceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenesMurine hepatoma (Hepa1c1c7) cells: a responsive in vitro system for chemoprotective enzyme induction by organoselenium compounds.Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetesMechanism of selenium-induced inhibition of arsenic-enhanced UVR carcinogenesis in mice.Human Lung Cancer Cell Line A-549 ATCC Is Differentially Affected by Supranutritional Organic and Inorganic Selenium.Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity.Sodium selenite increases the activity of the tumor suppressor protein, PTEN, in DU-145 prostate cancer cells.Selenium as a chemopreventive agent in experimentally induced colon carcinogenesisFunctional expression of rat thioredoxin reductase: selenocysteine insertion sequence element is essential for the active enzyme
P2860
Q24531944-7EA38E3B-A79E-4EA3-9C49-8775568A79C2Q28115980-B336A41E-B935-46E4-8487-DC93507191C9Q28343486-793A0584-8145-417A-B084-00C3C4E6FCAFQ33636981-A0745880-0CEE-40DD-BB80-928CB9B8DF1BQ33652577-E9EF851B-FC7A-4FAE-83BA-BFCF8FBABEDAQ33662334-B56660DF-876F-4D24-B0BD-95636803E0EEQ35535940-D6FAEF9E-9E7A-4F93-A215-A3DB906B11F5Q35652834-F356E968-A587-4634-82AA-521221C5E74EQ36404284-D34E46E0-B7E6-4898-8857-BA88E9337AD4Q36725357-D5C73F0C-EAD9-4118-815B-68E0DC749174Q38932012-58F718C2-9960-4E3D-8CC4-6A3159F14EAEQ39794894-D14BDBC7-85C4-4EA4-8C16-636C6074CF92Q39859930-3461F5B3-DDCA-49D3-9C76-D66111B143F7Q41135624-F4D309E1-4769-478B-AA8C-B45D608516CDQ42158832-47CCA3FC-5437-4BE6-A482-CA0F2342249C
P2860
Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Mechanisms of the regulation o ...... hemopreventive agent selenium.
@en
type
label
Mechanisms of the regulation o ...... hemopreventive agent selenium.
@en
prefLabel
Mechanisms of the regulation o ...... hemopreventive agent selenium.
@en
P2093
P1433
P1476
Mechanisms of the regulation o ...... hemopreventive agent selenium.
@en
P2093
P304
P407
P577
1997-11-01T00:00:00Z